Prognosis of patients with liver cirrhosis: A multi‐center retrospective observational study

Aim Despite advances in the management of liver diseases and changes in the etiology of cirrhosis, few studies have updated the prognosis of cirrhosis. This study aimed to clarify the recent prognosis of cirrhosis and identify risk factors for death. Methods In this retrospective observational study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology research 2021-12, Vol.51 (12), p.1196-1206
Hauptverfasser: Yamana, Hayato, Imai, Shinobu, Yamasaki, Kazumi, Horiguchi, Hiromasa, Ario, Keisuke, Komatsu, Tatsuji, Sugimoto, Rie, Katsushima, Shinji, Naganuma, Atsushi, Mano, Yutaka, Yamashita, Tsutomu, Kamitsukasa, Hiroshi, Tsuruta, Satoru, Jo, Taisuke, Yasunaga, Hideo, Fushimi, Kiyohide, Yatsuhashi, Hiroshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1206
container_issue 12
container_start_page 1196
container_title Hepatology research
container_volume 51
creator Yamana, Hayato
Imai, Shinobu
Yamasaki, Kazumi
Horiguchi, Hiromasa
Ario, Keisuke
Komatsu, Tatsuji
Sugimoto, Rie
Katsushima, Shinji
Naganuma, Atsushi
Mano, Yutaka
Yamashita, Tsutomu
Kamitsukasa, Hiroshi
Tsuruta, Satoru
Jo, Taisuke
Yasunaga, Hideo
Fushimi, Kiyohide
Yatsuhashi, Hiroshi
description Aim Despite advances in the management of liver diseases and changes in the etiology of cirrhosis, few studies have updated the prognosis of cirrhosis. This study aimed to clarify the recent prognosis of cirrhosis and identify risk factors for death. Methods In this retrospective observational study by the Hepatic Disease Network of the National Hospital Organization in Japan, chart reviews were performed to follow patients with cirrhosis beginning in 2011. We conducted Kaplan–Meier survival time analyses stratified by Child–Pugh classification and albumin‐bilirubin grade. Cox regression analysis was used to identify risk factors for death. Results We identified 444 eligible patients from 25 hospitals, including 303 (68%), 110 (25%), and 31 (7%) patients with Child–Pugh classes A, B, and C, respectively. Hepatitis C virus infection was the cause of cirrhosis for 63% of the patients. The 1‐year and 5‐year cumulative survival rates of patients with Child–Pugh classes A, B, and C were 90% and 61%, 78% and 42%, and 65% and 25%, respectively. The 1‐year and 5‐year cumulative survival rates of patients with albumin‐bilirubin grades 1, 2, and 3 were 98% and 80%, 91% and 56%, and 58% and 23%, respectively. Cirrhosis classification (Child–Pugh and albumin‐bilirubin), age, liver cancer, and untreated esophageal varices were associated with increased hazard of death. Conclusions Little improvement was observed in the prognosis of cirrhosis compared with previous reports, and the prognosis of Child–Pugh class C cirrhosis remained poor. Untreated esophageal varices were identified as a risk factor for death.
doi_str_mv 10.1111/hepr.13711
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2570374635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2604678790</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3941-58375b32bdc831a9197db42282e17404946209d08ebcf9a1541ea052586b33b73</originalsourceid><addsrcrecordid>eNp90M9LwzAUB_AgCs7pxb8g4EWEzvxqk3obYzph4BAFT5Y2TV1G19Qk3djNP8G_0b_EzHryYC4J5PMe730BOMdohMO5XqrWjjDlGB-AARacRIiyl8PwpiKJEsqSY3Di3AohzBFhA_C6sOatMU47aCrY5l6rxju41X4Ja71RFkpt7XIPbuAYrrva66-PTxlU-LPKW-NaJX2g0BRO2U1oYZq8hs535e4UHFV57dTZ7z0Ez7fTp8ksmj_c3U_G80jSlOEoFpTHBSVFKQXFeYpTXhaMEEEU5gyxlCUEpSUSqpBVmuOYYZWjmMQiKSgtOB2Cy75va817p5zP1tpJVdd5o0znMhJzRDlLaBzoxR-6Mp0NEweVIJZwwVMU1FWvZFjQWVVlrdXr3O4yjLJ91Nk-6uwn6oBxj7e6Vrt_ZDabLh77mm9H6IH-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604678790</pqid></control><display><type>article</type><title>Prognosis of patients with liver cirrhosis: A multi‐center retrospective observational study</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yamana, Hayato ; Imai, Shinobu ; Yamasaki, Kazumi ; Horiguchi, Hiromasa ; Ario, Keisuke ; Komatsu, Tatsuji ; Sugimoto, Rie ; Katsushima, Shinji ; Naganuma, Atsushi ; Mano, Yutaka ; Yamashita, Tsutomu ; Kamitsukasa, Hiroshi ; Tsuruta, Satoru ; Jo, Taisuke ; Yasunaga, Hideo ; Fushimi, Kiyohide ; Yatsuhashi, Hiroshi</creator><creatorcontrib>Yamana, Hayato ; Imai, Shinobu ; Yamasaki, Kazumi ; Horiguchi, Hiromasa ; Ario, Keisuke ; Komatsu, Tatsuji ; Sugimoto, Rie ; Katsushima, Shinji ; Naganuma, Atsushi ; Mano, Yutaka ; Yamashita, Tsutomu ; Kamitsukasa, Hiroshi ; Tsuruta, Satoru ; Jo, Taisuke ; Yasunaga, Hideo ; Fushimi, Kiyohide ; Yatsuhashi, Hiroshi</creatorcontrib><description>Aim Despite advances in the management of liver diseases and changes in the etiology of cirrhosis, few studies have updated the prognosis of cirrhosis. This study aimed to clarify the recent prognosis of cirrhosis and identify risk factors for death. Methods In this retrospective observational study by the Hepatic Disease Network of the National Hospital Organization in Japan, chart reviews were performed to follow patients with cirrhosis beginning in 2011. We conducted Kaplan–Meier survival time analyses stratified by Child–Pugh classification and albumin‐bilirubin grade. Cox regression analysis was used to identify risk factors for death. Results We identified 444 eligible patients from 25 hospitals, including 303 (68%), 110 (25%), and 31 (7%) patients with Child–Pugh classes A, B, and C, respectively. Hepatitis C virus infection was the cause of cirrhosis for 63% of the patients. The 1‐year and 5‐year cumulative survival rates of patients with Child–Pugh classes A, B, and C were 90% and 61%, 78% and 42%, and 65% and 25%, respectively. The 1‐year and 5‐year cumulative survival rates of patients with albumin‐bilirubin grades 1, 2, and 3 were 98% and 80%, 91% and 56%, and 58% and 23%, respectively. Cirrhosis classification (Child–Pugh and albumin‐bilirubin), age, liver cancer, and untreated esophageal varices were associated with increased hazard of death. Conclusions Little improvement was observed in the prognosis of cirrhosis compared with previous reports, and the prognosis of Child–Pugh class C cirrhosis remained poor. Untreated esophageal varices were identified as a risk factor for death.</description><identifier>ISSN: 1386-6346</identifier><identifier>EISSN: 1872-034X</identifier><identifier>DOI: 10.1111/hepr.13711</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc</publisher><subject>Albumin ; Bilirubin ; Cirrhosis ; Classification ; Cohort analysis ; cohort studies ; Death ; Esophagus ; Etiology ; Hepatitis C ; Liver cancer ; Liver cirrhosis ; Liver diseases ; Medical prognosis ; mortality ; Observational studies ; Patients ; Prognosis ; Risk factors ; Survival</subject><ispartof>Hepatology research, 2021-12, Vol.51 (12), p.1196-1206</ispartof><rights>2021 The Authors. Hepatology Research published by John Wiley &amp; Sons Australia, Ltd on behalf of Japan Society of Hepatology.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3941-58375b32bdc831a9197db42282e17404946209d08ebcf9a1541ea052586b33b73</citedby><cites>FETCH-LOGICAL-c3941-58375b32bdc831a9197db42282e17404946209d08ebcf9a1541ea052586b33b73</cites><orcidid>0000-0001-5487-3403</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhepr.13711$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhepr.13711$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids></links><search><creatorcontrib>Yamana, Hayato</creatorcontrib><creatorcontrib>Imai, Shinobu</creatorcontrib><creatorcontrib>Yamasaki, Kazumi</creatorcontrib><creatorcontrib>Horiguchi, Hiromasa</creatorcontrib><creatorcontrib>Ario, Keisuke</creatorcontrib><creatorcontrib>Komatsu, Tatsuji</creatorcontrib><creatorcontrib>Sugimoto, Rie</creatorcontrib><creatorcontrib>Katsushima, Shinji</creatorcontrib><creatorcontrib>Naganuma, Atsushi</creatorcontrib><creatorcontrib>Mano, Yutaka</creatorcontrib><creatorcontrib>Yamashita, Tsutomu</creatorcontrib><creatorcontrib>Kamitsukasa, Hiroshi</creatorcontrib><creatorcontrib>Tsuruta, Satoru</creatorcontrib><creatorcontrib>Jo, Taisuke</creatorcontrib><creatorcontrib>Yasunaga, Hideo</creatorcontrib><creatorcontrib>Fushimi, Kiyohide</creatorcontrib><creatorcontrib>Yatsuhashi, Hiroshi</creatorcontrib><title>Prognosis of patients with liver cirrhosis: A multi‐center retrospective observational study</title><title>Hepatology research</title><description>Aim Despite advances in the management of liver diseases and changes in the etiology of cirrhosis, few studies have updated the prognosis of cirrhosis. This study aimed to clarify the recent prognosis of cirrhosis and identify risk factors for death. Methods In this retrospective observational study by the Hepatic Disease Network of the National Hospital Organization in Japan, chart reviews were performed to follow patients with cirrhosis beginning in 2011. We conducted Kaplan–Meier survival time analyses stratified by Child–Pugh classification and albumin‐bilirubin grade. Cox regression analysis was used to identify risk factors for death. Results We identified 444 eligible patients from 25 hospitals, including 303 (68%), 110 (25%), and 31 (7%) patients with Child–Pugh classes A, B, and C, respectively. Hepatitis C virus infection was the cause of cirrhosis for 63% of the patients. The 1‐year and 5‐year cumulative survival rates of patients with Child–Pugh classes A, B, and C were 90% and 61%, 78% and 42%, and 65% and 25%, respectively. The 1‐year and 5‐year cumulative survival rates of patients with albumin‐bilirubin grades 1, 2, and 3 were 98% and 80%, 91% and 56%, and 58% and 23%, respectively. Cirrhosis classification (Child–Pugh and albumin‐bilirubin), age, liver cancer, and untreated esophageal varices were associated with increased hazard of death. Conclusions Little improvement was observed in the prognosis of cirrhosis compared with previous reports, and the prognosis of Child–Pugh class C cirrhosis remained poor. Untreated esophageal varices were identified as a risk factor for death.</description><subject>Albumin</subject><subject>Bilirubin</subject><subject>Cirrhosis</subject><subject>Classification</subject><subject>Cohort analysis</subject><subject>cohort studies</subject><subject>Death</subject><subject>Esophagus</subject><subject>Etiology</subject><subject>Hepatitis C</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Medical prognosis</subject><subject>mortality</subject><subject>Observational studies</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Risk factors</subject><subject>Survival</subject><issn>1386-6346</issn><issn>1872-034X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp90M9LwzAUB_AgCs7pxb8g4EWEzvxqk3obYzph4BAFT5Y2TV1G19Qk3djNP8G_0b_EzHryYC4J5PMe730BOMdohMO5XqrWjjDlGB-AARacRIiyl8PwpiKJEsqSY3Di3AohzBFhA_C6sOatMU47aCrY5l6rxju41X4Ja71RFkpt7XIPbuAYrrva66-PTxlU-LPKW-NaJX2g0BRO2U1oYZq8hs535e4UHFV57dTZ7z0Ez7fTp8ksmj_c3U_G80jSlOEoFpTHBSVFKQXFeYpTXhaMEEEU5gyxlCUEpSUSqpBVmuOYYZWjmMQiKSgtOB2Cy75va817p5zP1tpJVdd5o0znMhJzRDlLaBzoxR-6Mp0NEweVIJZwwVMU1FWvZFjQWVVlrdXr3O4yjLJ91Nk-6uwn6oBxj7e6Vrt_ZDabLh77mm9H6IH-</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Yamana, Hayato</creator><creator>Imai, Shinobu</creator><creator>Yamasaki, Kazumi</creator><creator>Horiguchi, Hiromasa</creator><creator>Ario, Keisuke</creator><creator>Komatsu, Tatsuji</creator><creator>Sugimoto, Rie</creator><creator>Katsushima, Shinji</creator><creator>Naganuma, Atsushi</creator><creator>Mano, Yutaka</creator><creator>Yamashita, Tsutomu</creator><creator>Kamitsukasa, Hiroshi</creator><creator>Tsuruta, Satoru</creator><creator>Jo, Taisuke</creator><creator>Yasunaga, Hideo</creator><creator>Fushimi, Kiyohide</creator><creator>Yatsuhashi, Hiroshi</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5487-3403</orcidid></search><sort><creationdate>202112</creationdate><title>Prognosis of patients with liver cirrhosis: A multi‐center retrospective observational study</title><author>Yamana, Hayato ; Imai, Shinobu ; Yamasaki, Kazumi ; Horiguchi, Hiromasa ; Ario, Keisuke ; Komatsu, Tatsuji ; Sugimoto, Rie ; Katsushima, Shinji ; Naganuma, Atsushi ; Mano, Yutaka ; Yamashita, Tsutomu ; Kamitsukasa, Hiroshi ; Tsuruta, Satoru ; Jo, Taisuke ; Yasunaga, Hideo ; Fushimi, Kiyohide ; Yatsuhashi, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3941-58375b32bdc831a9197db42282e17404946209d08ebcf9a1541ea052586b33b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Albumin</topic><topic>Bilirubin</topic><topic>Cirrhosis</topic><topic>Classification</topic><topic>Cohort analysis</topic><topic>cohort studies</topic><topic>Death</topic><topic>Esophagus</topic><topic>Etiology</topic><topic>Hepatitis C</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Medical prognosis</topic><topic>mortality</topic><topic>Observational studies</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Risk factors</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamana, Hayato</creatorcontrib><creatorcontrib>Imai, Shinobu</creatorcontrib><creatorcontrib>Yamasaki, Kazumi</creatorcontrib><creatorcontrib>Horiguchi, Hiromasa</creatorcontrib><creatorcontrib>Ario, Keisuke</creatorcontrib><creatorcontrib>Komatsu, Tatsuji</creatorcontrib><creatorcontrib>Sugimoto, Rie</creatorcontrib><creatorcontrib>Katsushima, Shinji</creatorcontrib><creatorcontrib>Naganuma, Atsushi</creatorcontrib><creatorcontrib>Mano, Yutaka</creatorcontrib><creatorcontrib>Yamashita, Tsutomu</creatorcontrib><creatorcontrib>Kamitsukasa, Hiroshi</creatorcontrib><creatorcontrib>Tsuruta, Satoru</creatorcontrib><creatorcontrib>Jo, Taisuke</creatorcontrib><creatorcontrib>Yasunaga, Hideo</creatorcontrib><creatorcontrib>Fushimi, Kiyohide</creatorcontrib><creatorcontrib>Yatsuhashi, Hiroshi</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamana, Hayato</au><au>Imai, Shinobu</au><au>Yamasaki, Kazumi</au><au>Horiguchi, Hiromasa</au><au>Ario, Keisuke</au><au>Komatsu, Tatsuji</au><au>Sugimoto, Rie</au><au>Katsushima, Shinji</au><au>Naganuma, Atsushi</au><au>Mano, Yutaka</au><au>Yamashita, Tsutomu</au><au>Kamitsukasa, Hiroshi</au><au>Tsuruta, Satoru</au><au>Jo, Taisuke</au><au>Yasunaga, Hideo</au><au>Fushimi, Kiyohide</au><au>Yatsuhashi, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognosis of patients with liver cirrhosis: A multi‐center retrospective observational study</atitle><jtitle>Hepatology research</jtitle><date>2021-12</date><risdate>2021</risdate><volume>51</volume><issue>12</issue><spage>1196</spage><epage>1206</epage><pages>1196-1206</pages><issn>1386-6346</issn><eissn>1872-034X</eissn><abstract>Aim Despite advances in the management of liver diseases and changes in the etiology of cirrhosis, few studies have updated the prognosis of cirrhosis. This study aimed to clarify the recent prognosis of cirrhosis and identify risk factors for death. Methods In this retrospective observational study by the Hepatic Disease Network of the National Hospital Organization in Japan, chart reviews were performed to follow patients with cirrhosis beginning in 2011. We conducted Kaplan–Meier survival time analyses stratified by Child–Pugh classification and albumin‐bilirubin grade. Cox regression analysis was used to identify risk factors for death. Results We identified 444 eligible patients from 25 hospitals, including 303 (68%), 110 (25%), and 31 (7%) patients with Child–Pugh classes A, B, and C, respectively. Hepatitis C virus infection was the cause of cirrhosis for 63% of the patients. The 1‐year and 5‐year cumulative survival rates of patients with Child–Pugh classes A, B, and C were 90% and 61%, 78% and 42%, and 65% and 25%, respectively. The 1‐year and 5‐year cumulative survival rates of patients with albumin‐bilirubin grades 1, 2, and 3 were 98% and 80%, 91% and 56%, and 58% and 23%, respectively. Cirrhosis classification (Child–Pugh and albumin‐bilirubin), age, liver cancer, and untreated esophageal varices were associated with increased hazard of death. Conclusions Little improvement was observed in the prognosis of cirrhosis compared with previous reports, and the prognosis of Child–Pugh class C cirrhosis remained poor. Untreated esophageal varices were identified as a risk factor for death.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1111/hepr.13711</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-5487-3403</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1386-6346
ispartof Hepatology research, 2021-12, Vol.51 (12), p.1196-1206
issn 1386-6346
1872-034X
language eng
recordid cdi_proquest_miscellaneous_2570374635
source Wiley Online Library Journals Frontfile Complete
subjects Albumin
Bilirubin
Cirrhosis
Classification
Cohort analysis
cohort studies
Death
Esophagus
Etiology
Hepatitis C
Liver cancer
Liver cirrhosis
Liver diseases
Medical prognosis
mortality
Observational studies
Patients
Prognosis
Risk factors
Survival
title Prognosis of patients with liver cirrhosis: A multi‐center retrospective observational study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T12%3A05%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognosis%20of%20patients%20with%20liver%20cirrhosis:%20A%20multi%E2%80%90center%20retrospective%20observational%20study&rft.jtitle=Hepatology%20research&rft.au=Yamana,%20Hayato&rft.date=2021-12&rft.volume=51&rft.issue=12&rft.spage=1196&rft.epage=1206&rft.pages=1196-1206&rft.issn=1386-6346&rft.eissn=1872-034X&rft_id=info:doi/10.1111/hepr.13711&rft_dat=%3Cproquest_cross%3E2604678790%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604678790&rft_id=info:pmid/&rfr_iscdi=true